GEHC GE HealthCare
FY2025 10-K
GE HealthCare (GEHC) filed its fiscal year 2025 10-K annual report with the SEC on Feb 4, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: global healthcare solutions provider delivering advanced medical tech, diagnostics, AI, cloud, and software for personalized patient care
- • New emphasis on AI-enabled software solutions upgradeable through equipment lifecycle, enhancing multi-site healthcare network operations
Management Discussion & Analysis
- • Revenue $20,625M, up 4.8% YoY; Product sales $13,661M (+4.5%, +$586M), Services $6,964M (+5.6%, +$368M)
- • Operating income $2,763M (13.4% margin vs 13.3%), net income $2,084M (10.1% margin, flat YoY)
Risk Factors
- • US tariffs on global imports in 2025 materially reduced profitability and cash flows, with ongoing risk of additional tariffs impacting financial results
- • Russia-Ukraine conflict and resulting US, EU sanctions increased costs and restricted supply to Russian customers, with uncertain license approvals from US authorities
Financial SummaryXBRL
Revenue
$20.6B
Net Income
$2.1B
Gross Margin
40.0%
Operating Margin
13.4%
Net Margin
10.1%
ROE
20.1%
Total Assets
$36.9B
EPS (Diluted)
$4.55
Operating Cash Flow
$2.0B
Source: XBRL data from GE HealthCare FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on GE HealthCare
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.